Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today announced that it was named one of five startups poised to change MedTech forever by Medical Device & Diagnostic Industry Magazine. MD+DI 's editorial quality and reliability has won it an unparalleled degree of trust from the industry.
For more than 30 years, MD+DI has served the industry as the leading source of in-depth news and information; many of their articles have become standards of reference for the medical device industry.
"We are honored to be recognized by MD+DI," said Nathan Harding, Company CEO. "It validates our drive to define the industry for exoskeletons, and, as Arundhati Parmar, MD + DI's Editor and article author states we have taken great strides."
Ekso Bionics designs, develops, and commercializes exoskeletons, or wearable robots, which have a variety of applications in the medical, military, industrial, and consumer markets. Exoskeletons are ready-to-wear, battery-powered robots that are strapped over the user's clothing, enabling individuals to achieve mobility, strength, and endurance not otherwise possible.
Ekso Bionics' lead product, EksoTM, is a wearable bionics suit that enables individuals with any amount of lower extremity weakness to stand up and walk over ground. Ekso is forging a new frontier in rehabilitation for people living with the consequences of stroke, spinal cord injury and other neurological conditions affecting gait.
About Ekso Bionics
Since 2005, Ekso Bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company's first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable.